The GLP-1 market is projected to reach $578.9M by 2030, growing at a 27.5% CAGR a massive opportunity for Indias health and pharma sectors
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, et al
lpha and Beta Hydroxy Acids of Bilberry, Sugar Cane, Sugar Maple, Orange, Lemon, and Willow Bark Extracts are blended together in this special formula to enhance skin tone and skin smoothness with exfoliation
FAST-ABSORBING SERUM
Medical Considerations Low IGF-1 with symptoms of GH deficiency may warrant: GH stimulation testing Consideration of GH or peptide therapy under endocrinology or functional medicine guidance High IGF-1 may require: Acromegaly screening (IGF-1 + oral glucose tolerance GH suppression test) Adjustment of therapy dosages Cancer risk assessment and monitoring IGF-1, Longevity, and Health Span The relationship between IGF-1 and lifespan is U-shaped both extremes are associated with higher risk
The slow dose escalation exists specifically to minimise side effects while the body adjusts
